← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1995Last known activity
Oct 31, 2021
Timeline
1970s
- Jan 1, 1976
Health Sciences Centre Foundation, Manitoba— Founded
Drugs by trial phase (7 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Communicable Diseases
- Fatigue
- Hypertension
- Hypertension, Pulmonary
- Infections
- Influenza, Human
- Multiple Sclerosis
- Muscle Spasticity
- Neuralgia
- Persistent Fetal Circulation Syndrome
- Pneumonia
- Pneumonia, Aspiration
- Pulmonary Valve Insufficiency
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Respiratory Tract Diseases
- Respiratory Tract Infections
- RNA Virus Infections
- Sclerosis
- Spinal Cord Injuries
- Syndrome
- Virus Diseases
Recent trials (7)
- NCT05093075CollaboratorPhase 2Oct 31, 2021
- NCT04803747CollaboratorPhase 4May 15, 2021
- NCT02022163CollaboratorPhase 1Dec 1, 2013
- NCT01222468CollaboratorPhase 2Jun 1, 2012
- NCT01516554Reponsible party - principal investigatorPhase 2Feb 1, 2012
- NCT01516554Lead sponsorPhase 2Feb 1, 2012
- NCT00005776Overall official - principal investigatorPhase 3Oct 1, 1995
Details
- Founded
- Winnipeg, CA Jan 1, 1976
- Last known activity
- Oct 31, 2021